Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cyclopharm Limited (AU:CYC)
ASX:CYC
RESEARCH TOOLSreports
Holding AU:CYC?
Track your performance easily
CYC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.33 - AU$2.17
Previous CloseAU$1.38
Volume459.00
Average Volume (3M)46.81K
Market Cap
AU$152.81M
Enterprise ValueAU$136.85M
Total Cash (Recent Filing)AU$20.30M
Total Debt (Recent Filing)AU$4.33M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Feb 19, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 01, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares OutstandingN/A
10 Day Avg. Volume22,445
30 Day Avg. Volume46,814
Standard Deviation0.17
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)8.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.70Price Target Upside97.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cyclopharm Limited News
PremiumCompany Announcements
Cyclopharm Limited Shares Future Financial Outlook
PremiumCompany Announcements
Cyclopharm Secures Deal with US Veterans Administration
PremiumCompany Announcements
Cyclopharm Director’s Shareholding Surges
PremiumCompany Announcements
Cyclopharm Limited Reports H1 Financials and US GrowthPremiumCompany Announcements
Cyclopharm’s US Expansion Boosts Growth ProspectsPremiumCompany Announcements
Cyclopharm Limited Announces New Share QuotationPremiumCompany Announcements
Cyclopharm Limited Announces New Share Issue
PremiumCompany Announcements
Cyclopharm Director’s Shareholding BoostedOptions Prices
Currently, No data available
---
Ownership Overview
CYC FAQ
What was Cyclopharm Limited’s price range in the past 12 months?
Cyclopharm Limited lowest share price was AU$1.33 and its highest was AU$2.17 in the past 12 months.
What is Cyclopharm Limited’s market cap?
Currently, no data Available
When is Cyclopharm Limited’s upcoming earnings report date?
Cyclopharm Limited’s upcoming earnings report date is Feb 19, 2025 which is in 89 days.
How were Cyclopharm Limited’s earnings last quarter?
Cyclopharm Limited released its earnings results on Aug 26, 2024. The company reported -AU$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.078.
Is Cyclopharm Limited overvalued?
According to Wall Street analysts Cyclopharm Limited’s price is currently Undervalued.
Does Cyclopharm Limited pay dividends?
Cyclopharm Limited pays a Annually dividend of <AU$0.01 which represents an annual dividend yield of N/A. See more information on Cyclopharm Limited dividends here
What is Cyclopharm Limited’s EPS estimate?
Cyclopharm Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyclopharm Limited have?
Cyclopharm Limited has 111,136,850 shares outstanding.
What happened to Cyclopharm Limited’s price movement after its last earnings report?
Cyclopharm Limited reported an EPS of -AU$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.817%.
Which hedge fund is a major shareholder of Cyclopharm Limited?
Currently, no hedge funds are holding shares in AU:CYC
---
Cyclopharm Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$2.70 (97.08% Upside)
AU$2.70 (97.08% Upside)
Blogger Sentiment
Bullish
AU:CYC Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$50.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.92%
12-Months-Change
Fundamentals
Return on Equity
-22.59%
Trailing 12-Months
Asset Growth
29.98%
Trailing 12-Months
Company Description
Cyclopharm Limited
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.
---
CYC Stock 12 Month Forecast
Average Price Target
AU$2.70
▲(97.08% Upside)
Technical Analysis
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Holista Colltech Limited
―
Integral Diagnostics Ltd.
―
Genetic Signatures Ltd.
―
Best Analysts Covering CYC
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-31.04%
reiterated a buy rating 3 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -31.04% per trade.
---